These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 38394476)

  • 21. Racial/ethnicity disparities in invasive breast cancer among younger and older women: An analysis using multiple measures of population health.
    Hung MC; Ekwueme DU; Rim SH; White A
    Cancer Epidemiol; 2016 Dec; 45():112-118. PubMed ID: 27792934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction in Breast Cancer Death With Adjuvant Chemotherapy Among US Women According to Race, Ethnicity, and the 21-Gene Recurrence Score.
    Huang HC; Calip GS; Weiss J; Simons Y; Gadi VK; Danciu OC; Rauscher GH; Hoskins KF
    J Natl Compr Canc Netw; 2024 Jan; 22(1D):e237077. PubMed ID: 38190799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database.
    Bagegni NA; Tao Y; Ademuyiwa FO
    PLoS One; 2019; 14(9):e0222358. PubMed ID: 31536530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
    Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
    JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.
    Cho B; Han Y; Lian M; Colditz GA; Weber JD; Ma C; Liu Y
    JAMA Oncol; 2021 Jul; 7(7):1016-1023. PubMed ID: 33983438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.
    Carroll JF; Hoskin TL; Leon-Ferre RA; Boughey JC
    Ann Surg Oncol; 2024 Aug; 31(8):5132-5140. PubMed ID: 38872043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer.
    Lee DY; Teng A; Pedersen RC; Tavangari FR; Attaluri V; McLemore EC; Stern SL; Bilchik AJ; Goldfarb MR
    Ann Surg Oncol; 2017 Feb; 24(2):311-318. PubMed ID: 27766558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
    Bassett MT; Chen JT; Krieger N
    PLoS Med; 2020 Oct; 17(10):e1003402. PubMed ID: 33079941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival Outcomes and Patterns of Care for Stage II or III Resected Gastric Cancer by Race and Ethnicity.
    Wu SP; Keshavjee SH; Yoon SS; Kwon S
    JAMA Netw Open; 2023 Dec; 6(12):e2349026. PubMed ID: 38127346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis.
    Li H; Plichta JK; Li K; Jin Y; Thomas SM; Ma F; Tang L; Wei Q; He YW; Chen Q; Guo Y; Liu Y; Zhang J; Luo S
    Breast Cancer Res Treat; 2024 Feb; 204(1):89-105. PubMed ID: 38066250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial.
    Rogers C; Cobb AN; Lloren JIC; Chaudhary LN; Johnson MK; Huang CC; Teshome M; Kong AL; Singh P; Cortina CS
    Breast Cancer Res Treat; 2024 Jan; 203(2):317-328. PubMed ID: 37864105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy.
    Luen SJ; Salgado R; Dieci MV; Vingiani A; Curigliano G; Gould RE; Castaneda C; D'Alfonso T; Sanchez J; Cheng E; Andreopoulou E; Castillo M; Adams S; Demaria S; Symmans WF; Michiels S; Loi S
    Ann Oncol; 2019 Feb; 30(2):236-242. PubMed ID: 30590484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial Disparities in Survival Outcomes of Patients With Serous Epithelial Ovarian Cancer: A Retrospective Cohort Analysis.
    Shingala K; Stavros S; Parag S; Tercek A; Makhani SS; Bouz A; Galbo A; Chung-Bridges K
    Cureus; 2023 Jan; 15(1):e34389. PubMed ID: 36874646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage Breast Cancer.
    Roy AM; Patel A; Catalfamo K; Attwood K; Khoury T; Yao S; Gandhi S
    JAMA Netw Open; 2023 Nov; 6(11):e2344517. PubMed ID: 37991763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between race and ethnicity and perioperative outcomes among women undergoing hysterectomy for adenomyosis.
    Meyer R; Maxey C; Hamilton KM; Nasseri Y; Barnajian M; Levin G; Truong MD; Wright KN; Siedhoff MT
    Fertil Steril; 2024 Jun; 121(6):1053-1062. PubMed ID: 38342374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials.
    Villegas SL; Nekljudova V; Pfarr N; Engel J; Untch M; Schrodi S; Holms F; Ulmer HU; Fasching PA; Weber KE; Albig C; Heinrichs C; Marmé F; Hartmann A; Hanusch C; Schmitt WD; Huober J; Lederer B; van Mackelenbergh M; Tesch H; Jackisch C; Rezai M; Sinn P; Sinn BV; Hackmann J; Kiechle M; Schneeweiss A; Weichert W; Denkert C; Loibl S
    Eur J Cancer; 2021 May; 148():159-170. PubMed ID: 33743484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disparities in Late-Stage Breast and Colorectal Cancer Diagnosis Among Hispanic, Non-Hispanic White, and Non-Hispanic Black Patients: a Retrospective Cohort Study of Texas Medicare Beneficiaries.
    Nicot-Cartsonis MS; Digbeu BDE; Raji MA; Kuo YF
    J Racial Ethn Health Disparities; 2023 Dec; 10(6):3168-3177. PubMed ID: 36575329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disparities at the Intersection of Race and Ethnicity: Examining Trends and Outcomes in Hispanic Women With Breast Cancer.
    Champion CD; Thomas SM; Plichta JK; Parrilla Castellar E; Rosenberger LH; Greenup RA; Hyslop T; Hwang ES; Fayanju OM
    JCO Oncol Pract; 2022 May; 18(5):e827-e838. PubMed ID: 33026950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial and Ethnic Disparities in Lung Adenocarcinoma Survival: A Competing-Risk Model.
    Wu X; Wang Y; Lin X; Wang Z; Xu J; Lv W; Hu J
    Clin Lung Cancer; 2020 May; 21(3):e171-e181. PubMed ID: 31787547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.